CD8+ T-cell responses identify β-cell autoimmunity in human type 1 diabetes

Diabetes

Volumn 56, Issue 3, 2007, Pages 613-621

  Mallone, Roberto ^a,b,f   Martinuzzi, Emanuela ^a,b   Blancou, Philippe ^c,d   Novelli, Giulia ^e   Afonso, Georgia ^a,b   Dolz, Manuel ^g   Bruno, Graziella ^e   Chaillous, Lucy ^g   Chatenoud, Lucienne ^a,b   Bach, Jean Marie ^c,d   Van Endert, Peter ^a,b,f  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d UNIVERSITY OF TURIN   (Italy)

^e HÔTEL DIEU   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATASE; GLUTAMATE DECARBOXYLASE; HLA A2 ANTIGEN; PREPROINSULIN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A2 ANTIGEN; HUMANS; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 33847338541     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1419     Document Type: Article

References (52)

1. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO: Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 345:1036-1040, 2001
2. Wong FS, Wen L, Tang M, Ramanathan M, Visintin I, Daugherty J, Hannum LG, Janeway CA Jr, Shlomchik MJ: Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 53:2581-2587, 2004
3. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS: Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365-1369, 1993
4. Hummel M, Durinovic-Bello I, Ziegler AG: Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J Autoimmun 9:427-430, 1996
5. Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarth GS: Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 40:564-572, 1997
6. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA: Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346:1692-1698, 2002
7. Nepom GT: Class II antigens and disease susceptibility. Annu Rev Med 46:17-25, 1995
8. Liblau RS, Wong FS, Mars LT, Santamaria P: Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity 17:1-6, 2002
9. Walter U, Santamaria P: CD8+ T cells in autoimmunity. Curr Opin Immunol 17:624-631, 2005
10. DiLorenzo TP, Serreze DV: The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol Rev 204:250-263, 2005
11. Wicker LS, Leiter EH, Todd JA, Renjilian RJ, Peterson E, Fischer PA, Podolin PL, Zijlstra M, Jaenisch R, Peterson LB: Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43:500-504, 1994
12. Serreze DV, Leiter EH, Christianson GJ, Greiner D, Roopenian DC: Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 43:505-509, 1994
13. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr: CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183:67-76, 1996
14. Graser RT, DiLorenzo TP, Wang F, Christianson GJ, Chapman HD, Roopenian DC, Nathenson SG, Serreze DV: Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 164:3913-3918, 2000
15. Nagata M, Santamaria P, Kawamura T, Utsugi T, Yoon JW: Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J Immunol 152:2042-2050, 1994
16. Wong FS, Karttunen J, Dumont C, Wen L, Visintin I, Pilip IM, Shastri N, Pamer EG, Janeway CA Jr: Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med 5:1026-1031, 1999
17. Amrani A, Verdaguer J, Serra P, Tafuro S, Tan R, Santamaria P: Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406:739-742, 2000
18. Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, Finegood DT, Santamaria P, Tan R: Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111:217-223, 2003
19. Marron MP, Graser RT, Chapman HD, Serreze DV: Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc Natl Acad Sci U S A 99:13753-13758, 2002
20. Takaki T, Marron MP, Mathews CE, Guttmann ST, Bottino R, Trucco M, DiLorenzo TP, Serreze DV: HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol 176:3257-3265, 2006
21. Hassainya Y, Garcia-Pons F, Kratzer R, Lindo V, Greer F, Lemonnier FA, Niedermann G, van Endert PM: Identification of naturally processed HLA-A2 restricted proinsulin epitopes by reverse immunology. Diabetes 54:2053-2059, 2005
22. van Endert P, Hassainya Y, Lindo V, Bach JM, Blancou P, Lemonnier F, Mallone R: HLA class I epitope discovery in type 1 diabetes. Ann N Y Acad Sci 1079:190-197, 2006
23. Toma A, Haddouk S, Briand JP, Camoin L, Gahery H, Connan F, Dubois-Laforgue D, Caillat-Zucman S, Guillet JG, Carel JC, Muller S, Choppin J, Boitard C: Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc Natl Acad Sci U S A 102:10581-10586, 2005
24. Pinkse GG, Tysma OH, Bergen CA, Kester MG, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW, Roep BO: Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci U S A 102:18425-18430, 2005
25. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (Suppl. 1):S5-S10, 2004
26. Parham P, Brodsky FM: Partial purification and some properties of BB7.2: a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 3:277-299, 1981
27. Bingley PJ, Bonifacio E, Mueller PW: Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 52:1128-1136, 2003
28. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219, 1999
29. Panina-Bordignon P, Lang R, van Endert PM, Benazzi E, Felix AM, Pastore RM, Spinas GA, Sinigaglia F: Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med 181:1923-1927, 1995
30. Nepom GT: Therapy of autoimmune diseases: clinical trials and new biologics. Curr Opin Immunol 14:812-815, 2002
31. Feldmann M, Steinman L: Design of effective immunotherapy for human autoimmunity. Nature 435:612-619, 2005
32. Serreze DV, Chen YG: Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans. Trends Immunol 26:603-607, 2005
33. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De BC, Seigneurin JM, De PP, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L: Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598-2608, 2005
34. Atkinson MA: ADA Outstanding Scientific Achievement Lecture 2004: Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease? Diabetes 54:1253-1263, 2005
35. Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC: Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study. Diabetes 55:2588-2594, 2006
36. Reijonen H, Novak EJ, Kochik S, Heninger A, Liu AW, Kwok WW, Nepom GT: Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51:1375-1382, 2002
37. Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M: Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 113:451-463, 2004
38. Danke NA, Koelle DM, Yee C, Beheray S, Kwok WW: Autoreactive T cells in healthy individuals. J Immunol 172:5967-5972, 2004
39. Yang J, Danke NA, Berger D, Reichstetter S, Reijonen H, Greenbaum C, Pihoker C, James EA, Kwok WW: Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J Immunol 176:2781-2789, 2006
40. Viglietta V, Kent SC, Orban T, Hafler DA: GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 109:895-903, 2002
41. Ouyang Q, Standifer NE, Qin H, Gottlieb P, Verchere CB, Nepom GT, Tan R, Panagiotopoulos C: Recognition of HLA class I-restricted β-cell epitopes in type 1 diabetes. Diabetes 55:3068-3074, 2006
42. Standifer NE, Ouyang Q, Panagiotopoulos C, Verchere CB, Tan R, Greenbaum CJ, Pihoker C, Nepom GT: Identification of novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes 55:3061-3067, 2006
43. Alleva DG, Crowe PD, Jin L, Kwok WW, Ling N, Gottschalk M, Conlon PJ, Gottlieb PA, Putnam AL, Gaur A: A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest 107:173-180, 2001
44. Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC: Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206-2212, 2005
45. Tree TI, Roep BO, Peakman M: Enhancing the sensitivity of assays to detect T cell reactivity: the effect of cell separation and cryopreservation media. Ann N Y Acad Sci 1037:26-32, 2004
46. Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA: Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus: report of the First International Workshop for Standardization of T Cell Assays. J Autoimmun 13:267-282, 1999
47. DCCT Research Group: Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT): the DCCT Research Group. J Clin Endocrinol Metab 65:30-36, 1987
48. Leslie RD, Delli CM: Age-dependent influences on the origins of autoimmune diabetes: evidence and implications. Diabetes 53:3033-3040, 2004
49. Schloot NC, Meierhoff G, Karlsson FM, Ott P, Putnam A, Lehmann P, Gottlieb P, Roep BO, Peakman M, Tree T: Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells: Report of the Third Immunology of Diabetes Society T-Cell Workshop. J Autoimmun 21:365-376, 2003
50. Brooks-Worrell BM, Starkebaum GA, Greenbaum C, Palmer JP: Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J Immunol 157:5668-5674, 1996
51. Brooks-Worrell B, Gersuk VH, Greenbaum C, Palmer JP: Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes. J Immunol 166:5265-5270, 2001
52. Dosch H, Cheung RK, Karges W, Pietropaolo M, Becker DJ: Persistent T cell anergy in human type 1 diabetes. J Immunol 163:6933-6940, 1999